Keeler T Homas Management LLC Gilead Sciences, Inc. Transaction History

Keeler T Homas Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 26, 2021	SELL	$56.65 - $64.55 $256,907 - $292,734	-4,535 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$62.1 - $78.08 $100,291 - $126,099	-1,615 Reduced 26.26%	4,535 $286,000
Q2 2020 Jul 17, 2020	SELL	$72.34 - $84.0 $36,170 - $42,000	-500 Reduced 7.52%	6,150 $473,000
Q1 2020 Apr 17, 2020	BUY	$62.63 - $80.22 $106,471 - $136,374	1,700 Added 34.34%	6,650 $497,000
Q4 2019 Jan 21, 2020	SELL	$61.62 - $67.78 $18,486 - $20,334	-300 Reduced 5.71%	4,950 $321,000
Q3 2019 Nov 04, 2019	BUY	$62.51 - $69.0 $9,376 - $10,350	150 Added 2.94%	5,250 $332,000
Q2 2019 Jul 31, 2019	BUY	$61.87 - $69.38 $6,187 - $6,938	100 Added 2.0%	5,100 $344,000
Q1 2019 Apr 30, 2019	BUY	$62.53 - $70.05 $37,518 - $42,030	600 Added 13.64%	5,000 $325,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $320,862 - $418,700	-5,300 Reduced 54.64%	4,400 $275,000
Q2 2018 Aug 02, 2018	SELL	$64.88 - $75.68 $38,928 - $45,408	-600 Reduced 5.83%	9,700 $687,000
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $732,845 - $860,256	10,300	10,300 $737,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Keeler T Homas Management LLC, based on Form 13F filings with the SEC.

Stay updated on Keeler T Homas Management LLC with notifications on news.